ABBV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbvie Inc

Watchlist Manager

Watchlist

Price: 248.08 USD -0.73% Market Closed

Market Cap: $438.3B

	Abbvie Inc NYSE:ABBV	US
	Takashimaya Co Ltd OTC:TKSHF	JP
B	BlackRock TCP Capital Corp F:8TC	US
L	Lumentum Holdings Inc DUS:LU2	US
	Centessa Pharmaceuticals PLC NASDAQ:CNTA	UK
	Persol Holdings Co Ltd OTC:TEMPF	JP
I	Ionis Pharmaceuticals Inc F:ISI	US
	Takashimaya Co Ltd F:TKM	JP
	Prysmian SpA F:AEU	IT
H	Heidelberg Pharma AG XHAM:HPHA	DE
	Arqit Quantum Inc NASDAQ:ARQQ	UK
O	Ollie's Bargain Outlet Holdings Inc SWB:OL6	US
S	Stryker Corp XMUN:SYK	US
	Cryoport Inc NASDAQ:CYRX	US
T	Tesla Inc XMUN:TL0	US

Profitability Summary

Abbvie Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

70% > 72%

Exceptional Operating Margin

34%

Strong 3Y Average Operating Margin

31%

Declining Operating Margin

36% > 34%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

15% > 7%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

35%

Declining Free Cash Flow Margin

44% > 29%

Exceptional ROE

15.222%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

16% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.